English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51234924    在线人数 :  788
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"sun h y"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 601-625 / 876 (共36页)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-09-30T03:22:25Z Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; Huang Y.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:24Z Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in taiwan: A multicenter cohort study Cheng C.-Y.; Tsai M.-S.; Yang C.-J.; Cheng S.-H.; Sun H.-Y.; Chang S.-F.; Su L.-H.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-Y.
臺大學術典藏 2020-09-30T03:22:24Z Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination Chen G.-J.; Lin K.-Y.; Sun H.-Y.; Sheng W.-H.; Hsieh S.-M.; Huang Y.-C.; Cheng A.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:24Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.; Hsieh S.-M.; Sheng W.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J.
臺大學術典藏 2020-09-30T03:22:23Z Dolutegravir-rilpivirine coformulation Sun H.-Y.; Chang S.-Y.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:23Z Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination Lin K.-Y.; Cheng A.; Sun H.-Y.; Chen G.-J.; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:23Z Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus–positive individuals during the outbreak of acute hepatitis A CHIEN-CHING HUNG; Chang S.-C.; Chen G.-J.; Lin K.-Y.; Hsieh S.-M.; Sun H.-Y.; Lo Y.-C.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Pan S.-C.
臺大學術典藏 2020-09-30T03:22:22Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.
臺大學術典藏 2020-09-30T03:22:22Z Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan Huang Y.-C.; Chen G.-J.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C.; Liu W.-D.;Tsai W.-C.;Hsu W.-T.;Shih M.-C.;Chen M.-Y.;Sun H.-Y.;Hsieh S.-M.;Sheng W.-H.;Chuang Y.-C.;Cheng A.;Lin K.-Y.;Huang Y.-S.;Huang S.-H.;Huang Y.-C.;Chen G.-J.;Wu P.-Y.;Chien-Ching Hung;Chang S.-C.; Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Lin K.-Y.; Huang Y.-S.; Huang S.-H.
臺大學術典藏 2020-09-30T03:22:21Z Performance of fracture risk assessment tool in HIV-positive male individuals aged ?45?years on suppressive antiretroviral therapy Tsai M.-S.; Zhang J.-Y.; Sun H.-Y.; Liu W.-C.; Wu P.-Y.; Yang C.-J.; CHIEN-CHING HUNG; Tsai M.-S.;Zhang J.-Y.;Sun H.-Y.;Liu W.-C.;Wu P.-Y.;Yang C.-J.;Chien-Ching Hung
臺大學術典藏 2020-09-30T03:22:20Z Molecular epidemiology of acute HCV infection in HIV–positive patients from Hong Kong, Taipei, Tokyo Wong B.C.K.; Chan D.P.C.; Sun H.-Y.; Uemura H.; Wong N.-S.; Lin P.-H.; Su L.-H.; CHIEN-CHING HUNG; Oka S.; Chang S.-Y.; Lee S.-S.
臺大學術典藏 2020-09-30T03:22:19Z Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients Liu W.-C.; CHIEN-CHING HUNG; Huang Y.-C.; Su Y.-C.; Chen G.-J.;Sun H.-Y.;Chang S.-Y.;Cheng A.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; Huang Y.-S.; Lin K.-Y.
臺大學術典藏 2020-09-30T03:22:19Z Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia Huang Y.-S.;Liu C.-E.;Lin S.-P.;Lee C.-H.;Yang C.-J.;Lin C.-Y.;Tang H.-J.;Lee Y.-C.;Lin Y.-C.;Lee Y.-T.;Sun H.-Y.;Chien-Ching Hung; Huang Y.-S.; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; Sun H.-Y.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:19Z Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy Chen G.-J.;Sun H.-Y.;Cheng A.;Chuang Y.-C.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Liu W.-C.;Wu P.-Y.;Chien-Ching Hung;Chang S.-C.; Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:19Z Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection Huang Y.-S.;Sun H.-Y.;Chang S.-Y.;Chuang Y.-C.;Cheng A.;Huang S.-H.;Huang Y.-C.;Chen G.-J.;Lin K.-Y.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:18Z Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:18Z Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan Wu P.-Y.; Chen M.-Y.; Sheng W.-H.; CHIEN-CHING HUNG; Wu U.-I.; Chang H.-Y.; Luo Y.-Z.; Yang S.-P.; Zhang J.-Y.; Sun H.-Y.; Pan S.-C.; Hsieh S.-M.; Chuang Y.-C.; Cheng A.
臺大學術典藏 2020-09-30T03:22:18Z Lumbar puncture for non-HIV-infected non-transplant patients with cryptococcosis: Should it be mandatory for all? Huang S.-H.;Chuang Y.-C.;Lee Y.-C.;Chien-Ching Hung;Sheng W.-H.;Su J.J.;Sun H.-Y.;Chen Y.-C.;Chang S.-C.; Huang S.-H.; Chuang Y.-C.; Lee Y.-C.; CHIEN-CHING HUNG; Sheng W.-H.; Su J.J.; Sun H.-Y.; Chen Y.-C.; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:17Z Hepatitis E Virus Infections Among Human Immunodeficiency Virus–Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan Chang S.-Y.; Liu W.-C.; Lin K.-Y.; Lin P.-H.; Sun H.-Y.; Chen Y.-T.; Su L.-H.; Su Y.-C.; Ho S.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:17Z HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan Huang M.-H.;Chang S.-Y.;Liu C.-H.;Cheng A.;Su L.-H.;Liu W.-C.;Su Y.-C.;Sun H.-Y.;Chien-Ching Hung;Chang S.-C.; Huang M.-H.; Chang S.-Y.; Liu C.-H.; Cheng A.; Su L.-H.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:16Z Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C.
臺大學術典藏 2020-09-30T03:22:16Z Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Ou S.-T.; Lin S.-W.; Huang W.-C.;Huang C.-K.;Huang S.-H.;Lin S.-W.;Ou S.-T.;Chen Y.-T.;Chen Y.-W.;Chang S.-Y.;Liu W.-C.;Sun H.-Y.;Chien-Ching Hung; Huang W.-C.; Huang C.-K.; Huang S.-H.
臺大學術典藏 2020-09-30T03:22:15Z Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide Kuo P.-H.;Sun H.-Y.;Chuang Y.-C.;Wu P.-Y.;Liu W.-C.;Chien-Ching Hung; Kuo P.-H.; Sun H.-Y.; Chuang Y.-C.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:14Z Effect of a Hepatitis A Vaccination Campaign During a Hepatitis A Outbreak in Taiwan, 2015-2017: A Modeling Study Chang S.-C.; Fang C.-T.; CHIEN-CHING HUNG; Cheng A.; Pan S.-C.; Sun H.-Y.; Chen Y.-H.; Lo Y.-C.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Lin K.-Y.; Lin K.-Y.;Sun H.-Y.;Chen Y.-H.;Lo Y.-C.;Hsieh S.-M.;Sheng W.-H.;Chuang Y.-C.;Pan S.-C.;Cheng A.;Chien-Ching Hung;Fang C.-T.;Chang S.-C.
臺大學術典藏 2020-09-30T03:22:14Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-H.;Liu C.-J.;Chien-Ching Hung;Hsieh S.-M.;Su T.-H.;Sun H.-Y.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.

显示项目 601-625 / 876 (共36页)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每页显示[10|25|50]项目